[Treatment of vomiting in children patients with solid tumor by hewei zhiou recipe combined ondansetron hydrochloride]
- PMID: 22803424
[Treatment of vomiting in children patients with solid tumor by hewei zhiou recipe combined ondansetron hydrochloride]
Abstract
Objective: To observe the therapeutic efficacy of Hewei Zhiou Recipe (HZR) combined ondansetron hydrochloride (OH) in treating vomiting in children patients with solid tumor.
Methods: Eighty children patients with solid tumor at the Department of Tumor, Beijing Children's Hospital from January 2007 to January 2010 were randomly assigned to the treatment group and the control group by the random digit table method, 40 in each group. OH 4 mg was intravenously dripped to patients in the control group. Those in the treatment group took HZR on the basis of the same treatment as for the control group. The vomiting score and degree of the two groups were collected and compared by the end of the 1st to the 6th therapeutic course.
Results: There was no statistical difference in the vomiting degree between the two groups by the end of the 1st therapeutic course (Z = -0.470, P>0.05). The vomiting degree was lessened in the treatment group by the end of the 2nd to the 6th therapeutic course, showing statistical difference when compared with the control group (Z = - 2.966, -3.256, -3.453, -4.870, -3.627, respectively, P<0.01).
Conclusion: HZR combined OH could effectively relieve the vomiting of children patients with solid tumor during chemotherapy.
Similar articles
-
[Effects of fuzheng jianpi decoction combined chemotherapy on the quality of life and the survival time of children with solid tumor].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Sep;32(9):1175-9. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012. PMID: 23185753 Clinical Trial. Chinese.
-
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].Gan To Kagaku Ryoho. 2002 Feb;29(2):273-9. Gan To Kagaku Ryoho. 2002. PMID: 11865634 Clinical Trial. Japanese.
-
Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children.J Med. 1993;24(2-3):161-70. J Med. 1993. PMID: 7691978
-
Parenteral ondansetron for the treatment of chemotherapy- and radiation-induced nausea and vomiting.Pharmacotherapy. 1992;12(2):120-31. Pharmacotherapy. 1992. PMID: 1533280 Review.
-
[Use of ondansetron, a 5-HT3 receptor antagonist, as a new type of antiemetic in pediatric oncology].Orv Hetil. 1993 Jun 20;134(25):1363-7. Orv Hetil. 1993. PMID: 8332356 Review. Hungarian.
Cited by
-
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review.Curr Oncol Rep. 2024 Jun;26(6):714-734. doi: 10.1007/s11912-024-01538-1. Epub 2024 May 11. Curr Oncol Rep. 2024. PMID: 38733465 Free PMC article. Review.
-
A systematic review of integrative clinical trials for supportive care in pediatric oncology: a report from the International Society of Pediatric Oncology, T&CM collaborative.Support Care Cancer. 2018 Feb;26(2):375-391. doi: 10.1007/s00520-017-3908-0. Epub 2017 Oct 13. Support Care Cancer. 2018. PMID: 29026997
-
Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.Cochrane Database Syst Rev. 2016 Feb 2;2(2):CD007786. doi: 10.1002/14651858.CD007786.pub3. Cochrane Database Syst Rev. 2016. PMID: 26836199 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical